Krystal Biotech, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $389.1 | $290.5 | $50.7 | $0.0 | $0.0 |
| Operating income | $161.3 | $65.7 | -$109.6 | -$145.2 | -$68.3 |
| Net income | $204.8 | $89.2 | $10.9 | -$140.0 | -$69.6 |
| Cash Flow Statement | |||||
| Free cash flow | $188.9 | $119.2 | -$100.6 | -$153.5 | -$116.3 |
Shares outstanding 29.6M · Free float 65.5%
Annual filing data through FY ended December 31, 2025; float as of September 12, 2026.